Compare Alcon AG (ALC) vs Vanguard Short Term Corporate Bond ETF (VCSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alcon AG vs Vanguard Short Term Corporate Bond ETF — how do they compare? Alcon AG trades at $74.19 (market cap $36.44B), while Vanguard Short Term Corporate Bond ETF trades at $78.52. The key difference: Alcon AG pays a 0.48% dividend while Vanguard Short Term Corporate Bond ETF pays none, and Alcon AG is trading nearer its 52-week high, Vanguard Short Term Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| ALC | VCSH | |
|---|---|---|
Market Cap | $36.44B | — |
Sector | Health | Fixed Income |
52-Week High | $90.12 | $80.20 |
52-Week Low | $62.02 | $78.41 |
Enterprise Value | $40.28B | — |
Dividend Yield | 0.48% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Vanguard Short Term Corporate Bond ETF
VCSH tracks the Bloomberg U.S. 1-5 Year Corporate Bond Index, focusing on high-quality, investment-grade debt with short maturities. It is designed to offer higher income than Treasury bills with significantly lower interest rate sensitivity than intermediate or long-term bond funds.
Read more on VCSH →
